key: cord-0273392-smzrzq21 authors: Gellenoncourt, Stacy; Saunders, Nell; Robinot, Rémy; Auguste, Lucas; Rajah, Maaran Michael; Kervevan, Jerôme; Jeger-Madiot, Raphaël; Staropoli, Isabelle; Planchais, Cyril; Mouquet, Hugo; Buchrieser, Julian; Schwartz, Olivier; Chakrabarti, Lisa A. title: The spike-stabilizing D614G mutation interacts with S1/S2 cleavage site mutations to promote the infectious potential of SARS-CoV-2 variants date: 2022-05-20 journal: bioRxiv DOI: 10.1101/2022.05.20.492832 sha: 1fafe293bfcce082280aeb90798fdf6c393fbf5e doc_id: 273392 cord_uid: smzrzq21 SARS-CoV-2 remained genetically stable during the first three months of the pandemic, before acquiring a D614G spike mutation that rapidly spread worldwide, and then generating successive waves of viral variants with increasingly high transmissibility. We set out to evaluate possible epistatic interactions between the early occurring D614G mutation and the more recently emerged cleavage site mutations present in spike of the Alpha, Delta, and Omicron variants of concern. The P681H/R mutations at the S1/S2 cleavage site increased spike processing and fusogenicity but limited its incorporation into pseudoviruses. In addition, the higher cleavage rate led to higher shedding of the spike S1 subunit, resulting in a lower infectivity of the P681H/R-carrying pseudoviruses compared to those expressing the Wuhan wild-type spike. The D614G mutation increased spike expression at the cell surface and limited S1 shedding from pseudovirions. As a consequence, the D614G mutation preferentially increased the infectivity of P681H/R-carrying pseudoviruses. This enhancement was more marked in cells where the endosomal route predominated, suggesting that more stable spikes could better withstand the endosomal environment. Taken together, these findings suggest that the D614G mutation stabilized S1/S2 association and enabled the selection of mutations that increased S1/S2 cleavage, leading to the emergence of SARS-CoV-2 variants expressing highly fusogenic spikes. AUTHOR SUMMARY The successive emergence of SARS-CoV-2 variants is fueling the COVID pandemic, thus causing a major and persistent public health issue. The parameters involved in the emergence of variants with higher pathogenic potential remain incompletely understood. The first SARS-CoV-2 variant that spread worldwide in early 2020 carried a D614G mutation in the viral spike, making this protein more stable in its cleaved form at the surface of virions, and resulting in viral particles with higher infectious capacity. The Alpha and the Delta variants that spread in late 2020 and early 2021, respectively, proved increasingly transmissible and pathogenic when compared to the original SARS-CoV-2 strain. Interestingly, Alpha and Delta both carried mutations in a spike cleavage site that needs to be processed by cellular proteases prior to viral entry. The cleavage site mutations P681H/R made the Alpha and Delta spikes more efficient at viral fusion, by generating a higher fraction of cleaved spikes subunits S1 and S2. We show here that the early D614G mutation and the late P681H/R mutations act synergistically to increase the fusion capacity of SARS-CoV-2 variants. Specifically, viruses with increased spike cleavage due to P681H/R were even more dependent on the stabilizing effect of D614G mutation, which limited the shedding of cleaved S1 subunits from viral particles. These findings suggest that the worldwide spread of the D614G mutation was a prerequisite to the emergence of more pathogenic SARS-CoV-2 variants with highly fusogenic spikes. The successive emergence of SARS-CoV-2 variants is fueling the COVID pandemic, thus causing a major 2 and persistent public health issue. The parameters involved in the emergence of variants with higher 3 pathogenic potential remain incompletely understood. The first SARS-CoV-2 variant that spread worldwide 4 in early 2020 carried a D614G mutation in the viral spike, making this protein more stable in its cleaved 5 form at the surface of virions, and resulting in viral particles with higher infectious capacity. The Alpha and 6 the Delta variants that spread in late 2020 and early 2021, respectively, proved increasingly transmissible 7 and pathogenic when compared to the original SARS-CoV-2 strain. Interestingly, Alpha and Delta both 8 carried mutations in a spike cleavage site that needs to be processed by cellular proteases prior to viral 9 entry. The cleavage site mutations P681H/R made the Alpha and Delta spikes more efficient at viral fusion, 10 by generating a higher fraction of cleaved spikes subunits S1 and S2. We show here that the early D614G 11 mutation and the late P681H/R mutations act synergistically to increase the fusion capacity of SARS-CoV- 12 2 variants. Specifically, viruses with increased spike cleavage due to P681H/R were even more dependent 13 on the stabilizing effect of D614G mutation, which limited the shedding of cleaved S1 subunits from viral 14 particles. These findings suggest that the worldwide spread of the D614G mutation was a prerequisite to 15 the emergence of more pathogenic SARS-CoV-2 variants with highly fusogenic spikes. [20, 21] . Further structural studies showed that D614G also had a key role in stabilizing the non-covalent 1 association of the S1 and S2 spike subunits once they were cleaved, through the ordering of a loop 2 reinforcing intra-protomer interactions [17, 22] . Thus, the D614G mutation made the spike more stable 3 but also more prone to interact with its receptor, accounting for the clear selective advantage conferred 4 to the virus. The N501Y mutation shared by the Alpha, Beta, and Gamma VOCs was shown to increase the affinity of 7 the spike for the ACE2 receptor, and to be sufficient to increase SARS-CoV-2 infectivity and transmissibility 8 in the hamster model [23] . Another group of spike mutations located close to the receptor binding motif, 9 and including the E484K, K417N/T, and L452R substitutions, is involved in the escape of VOCs from 10 neutralizing antibodies [1, 19] . A third group of VOC mutations are located in the vicinity of the S1/S2 11 cleavage site located at R685/S686, and may thus influence the processing of the spike. The original SARS- 12 CoV-2 Wuhan strain is characterized by the presence of a polybasic motif 681-PRRAR-685 just N-terminal 13 to the S1/S2 cleavage site, a feature unique among sarbecoviruses [24] . The polybasic motif is recognized 14 by the furin protease during spike export to the surface of infected cells, resulting in a partial cleavage of 15 the spike trimers incorporated into virion [25] . The cleavage at the S1/S2 site preactivates the spike, 16 making SARS-CoV-2 virions less dependent on proteases expressed at the surface of target cells for their 17 entry [26, 27] and more fit in vivo [28, 29] . Indeed, when the S1/S2 site is pre-cleaved, the spike bound to 18 the ACE2 receptor requires only a single additional cleavage at the S2' site to release the fusion peptide 19 and transition to a fusogenic conformation [30] . This additional cleavage may be provided by the surface 20 protease TMPRSS2, or by endosomal proteases such as cathepsin L if virions are endocytosed [4, 31, 32]. 21 22 Notably, several of the SARS-CoV-2 variants carry a mutation at P681, just upstream of the polybasic S1/S2 23 cleavage site (Fig 1) . The Alpha VOC and the Theta VOI carry a P681H change, which increase the local 24 positive charge, and may thus facilitate furin cleavage [33] . Indeed, SARS-CoV-2 spikes carrying the P681H 25 mutation were shown to be more cleaved and more fusogenic than their non-mutated counterparts in 26 most [34] [35] [36] , though not all studies [37] . Of note, the Alpha variant also carries a nearby T716I mutation 27 that may further influence spike cleavage. The Delta variant and the Kappa VOI carry a P681R mutation, 28 which further increases the basic nature of the S1/S2 cleavage motif. This mutation was shown to increase 29 the degree of cleavage at S1/S2, resulting in a spike that is even more fusogenic than that of Alpha [38, 30 39]. The P681R mutation provides a clear competitive advantage to Delta in terms of infectivity in cell 31 culture systems and in animal models of infection [38, 40] . More broadly, there has been a consistent 32 trend for increased S1/S2 cleavage in the different VOCs and VOIs that emerged in the past two years, 1 which may help account for their higher transmissibility and pathogenicity [35] . In contrast, the recently 2 emerged Omicron variant shows a low degree of S1/S2 cleavage in virions released in culture, even though 3 it carries the P681H mutation also found in the Alpha spike [14, 41] . The limited degree of precleavage 4 reported for the Omicron spike, and its preference for the endosomal rather than the TMPRSS2 entry 5 route, may contribute to the lower pathogenicity reported for this variant [16, 42] . 6 7 Phylogenetic analyses suggest that each VOC arose independently, rather than by sequential evolution 8 (Fig. 1) . However, it remains intriguing that VOCs did not arise prior to the selective sweep that replaced 9 the original Wuhan strain by the D614G-carrying variant. To address this issue, we assessed possible 10 epistatic interactions between D614G and the dominant S1/S2 cleavage site mutations. Analyses of 11 fusogenic capacity, spike processing, and infectivity of pseudotyped viruses did reveal interactions 12 between these two types of genetic changes. Specifically, the stabilizing effect of the D614G mutation 13 proved necessary to maintain the infectious capacity of virions carrying a highly fusogenic spike, pointing 14 to the critical role of D614G in enabling the emergence of the VOCs. 15 Design of spike mutations 18 The cleavage site mutations present in the SARS-CoV-2 VOCs were introduced into the spike sequence of 19 the reference Wuhan strain (Fig 2) . Specifically, we constructed spike-expressing phCMV vectors carrying 20 the punctual mutations P681H or T716I found in the Alpha variant, and P681R found in the Delta variant 21 (Fig 2A) . Of note, the P681H mutation is also present in the currently emerging Omicron variant. Controls 22 included a Wuhan spike with a deletion of the furin cleavage site (FCS) equivalent to that found in the 23 naturally occurring bat coronavirus RaTG13. This DFCS mutation corresponded to the deletion of aa 681-24 684 (PRRA), resulting in in a TNS/RSVA sequence at the S1/S2 junction. To evaluate interactions between 25 the early occurring D614G mutation and the more recently emerged cleavage site mutations, the Wuhan 26 (WT) and cleavage site mutant spikes were constructed in two versions, with or without the D614G 27 mutation ( Fig 2B) . As references, we also generated spikes carrying the full complement of mutations 28 present in the Alpha and Delta variants. Spike-expressing vectors were initially transfected in HEK 293Tn cells (hereafter HEK cells) to verify that 1 the spike proteins were properly expressed at the cell surface. Transfected cells were labelled with the 2 human monoclonal antibody mAb 129 known to cross-react with the S1 subunit of the SARS-CoV-2 variants 3 included in the study [36] . All of the vector tested resulted in efficient expression of the spike, with over 4 70% of HEK cells labeled with the mAb 129 antibody (Fig 3A-B and S1A Fig) . Analysis of the mean 5 fluorescence intensity (MFI) of transfected HEK cells showed that the DFCS spike deleted of the FCS was 6 expressed to higher levels (Fig 3C) , possibly because the S1 subunit could not be shed from the cell surface. 7 The difference in MFI between the WT and DFCS spikes proved significant only for the versions of the 8 spikes expressing G614. To systematically evaluate the effect of the D614G mutation on spike surface 9 expression, we computed the ratios of MFI for spike pairs carrying G614 or D614 (Fig 3E) . This analysis 10 showed that mean MFI ratios were above 1, suggesting that G614 increased spike surface expression. The 11 MFI ratio was significantly higher for WT spikes than P681R spikes, suggesting that the D614 effect was 12 modulated by spike cleavage. Similar trends were observed when analyzing the G614/D614 ratios of the 13 percentage of spike-expressing cells (Fig 3D) , though the difference between WT and P681R did not reach 14 significance. Overall, this analysis showed that both the FCS deletion and the D614G mutation promoted 15 spike expression at the cell surface. The DFCS spike did not induce detectable fusion (Fig 4B) , compatible with the notion that cleavage at the 26 FSC is required for SARS-CoV-2 spike-dependent fusion at the cell surface. In contrast, all of the other 27 spikes induced the formation of GFP+ syncytia, with the size of syncytia appearing larger for spikes carrying 28 the P681H/R mutations (Fig 4B) . Quantitative image analysis showed that the WT and T716I spikes had 29 equivalent fusogenic capacity ( Fig 4C) . In contrast, the P681H and P681R spikes induced significantly more 30 fusion than the WT spike (P<0.0001 in presence of D614; P<0.01 in the presence of G614), consistent with 31 previous findings by us and others [35, 36] . The Alpha and Delta spikes also proved strongly fusogenic, 1 compatible with the presence of the P681H and P681R mutations, respectively. Comparison of fusion achieved in presence and absence of the D614G mutation was measured by fusion 4 ratios ( Fig 4D) . This analysis showed that the D614G mutation increased the fusogenicity of the WT Wuhan 5 and T716I spikes, with ratios ≥1, possibly due to increased spike expression at the cell surface. In contrast, 6 the D614G effect was weak or absent for the already highly fusogenic spikes carrying P681H/R mutations. 7 8 Cleavage site mutations limit spike incorporation into pseudoviruses 9 Pseudotyped viruses (PV) were produced by co-transfecting HEK cells with a SARS-CoV-2 spike expression 10 vector, a GFP-lentivector backbone, and HIV-derived packaging plasmids. PV particles concentrated by 11 ultracentrifugation were analyzed for spike incorporation and processing by Western blotting. Dual 12 labeling was obtained with a polyclonal anti-S1 antibody (green fluorescence) and a monoclonal anti-S2 13 (red fluorescence), so that the uncleaved spike precursor S0 containing both the S1 and S2 subunits 14 appeared as yellow (Fig 5A, top panel) . PV protein extracts were normalized according to their content in 15 HIV p24 capsid protein (Fig 5A, bottom panel) . 16 Particle pseudotyped with the DFCS spike showed a highly predominant S0 band, as expected for a spike 18 devoid of an S1/S2 cleavage site. In contrast, S1 and S2 subunits were detected in PV expressing a spike 19 with an FCS. To evaluate the total amount of spike incorporated by the different PV, we measured the 20 summed intensities of the S2 and S0 bands (in the red channel), reported to the amount of p24 capsid 21 protein ( Fig 5B) . Of note, the (S0+S2)/p24 parameter takes into account all the spikes moieties 22 incorporated into the PV, irrespective of their cleavage status or of the possible shedding of the S1 subunit. 23 Quantitation of this parameter showed that all of the cleavage site mutations tended to decrease total 24 spike incorporation, with an effect that was more marked for the T716I mutant. The Alpha PV also showed 25 low spike incorporation compared to the WT G614 PV. Based on a G614/D614 ratio analysis (Fig 5C) , the 26 D614G mutation had minimal effect on total spike incorporation, except for a possible decrease in 27 incorporation of the P681R. The D614G mutation promotes spike cleavage but limits S1 shedding 30 We then analyzed the ratio of S2 subunit to S0 precursor, in order to evaluate the extent of spike cleavage 31 in PV particles. This analysis showed that the P681H/R mutations strongly promoted spike cleavage (Fig 32 5D ), consistent with the literature [34, 35, 38, 39] . The Delta PV also harbored almost fully cleaved spikes, 1 while this was not apparent for the Alpha PV, suggesting that other mutations such as T716I 2 counterbalanced the pro-cleavage effect of P681H. The G614/D614 ratio analysis showed that the 3 presence of the G614 mutation increased spike cleavage in the WT and T716I PV, but had no discernable 4 effect on the already highly cleaved spikes of the P681H and P681R PV (Fig 5E) . The relative amount of S1 subunit retained on the different PV was then measured by quantifying the 7 S1/S2 ratio (Fig 5F) . The T716I mutation was associated to a very low S1/S2 ratio relative to WT, while the 8 P681H/R mutations did not have a marked effect on the S1/S2 ratio. Thus, the T716I mutation induced 9 marked S1 shedding, while the addition of a basic amino acid in the FCS appeared neutral on shedding, 10 even though it increased spike cleavage. Presence of the D614G mutation promoted S1 retention in all the 11 PV tested, as shown by values above 2 in the G614/D614 ratio analysis relative to the S1/S2 parameter 12 ( Fig 5G) . In particular, D614G efficiently corrected the deleterious effect of T716I on S1 shedding. Taken 13 together, the D614G mutation promoted spike cleavage but limited S1 shedding, enabling the production 14 of viral particles with a high content of cleaved spike. Analysis of the G614/D614 infectivity ratios showed that the D614G mutation increased infectivity of the 5 WT, P681H, and P681R PV in HEK-ACE2, while this was not the case for the T716I and DFCS PV (Fig 6D) . 6 The enhancement of viral infectivity tended to be more marked at lower PV input doses, presumably 7 because of saturation of the readout and a degree of cytotoxicity observed at the highest input dose (S4B 8 Fig) . Interestingly, the effect of D614G was more marked for the PV carrying the basic P681R/H mutations 9 than for the WT, as shown by ratios ≥2 (Fig 6D, red line) , suggesting that D614G may have played a 10 compensatory role that was important in the emergence of the P681H/R-carrying variants. The Alpha PV 11 which retained relatively low infectivity in HEK-ACE2 cells (Fig 6B) , suggesting that mutations other than 12 D614G and P681H also impacted viral entry, with a possible negative role of T716I. The effect of D614G 13 was less apparent in HEK-ACE2-TMPRSS2 than in HEK-ACE2 cells, but remained more marked for the 14 P681R/H than the WT PV ( Fig 6C,E) , confirming that D614G preferentially increased the infectivity of PV 15 carrying the P681H/R basic mutations. The D614G mutation increases infectivity in different cellular contexts 18 To test the generality of these findings, we measured the infectivity of PV in the osteosarcoma cell lines 19 U2OS-ACE2 +/-TMPRSS2 and in the lung adenocarcinoma cell line Calu-3. As PV expressing a GFP reporter 20 gene gave a low detection signal in these cell lines, we switched to a PV system where the backbone 21 lentivector expressed luciferase, resulting in a higher signal to noise ratio (Fig 7) . The pattern of infectivity 22 observed in U2OS-ACE2 was similar to that observed in HEK-ACE2, with a relative defect of the T716I, 23 P681H and P681R PV compared to WT, and a highly efficient entry of the DFCS PV ( Fig 7A) . The D614G 24 mutation markedly increased PV infectivity in U2OS-ACE2 cells (Fig 7B) , with a partial restoration of 25 infectivity for the P681H/R mutants. The Alpha PV showed an infectivity equivalent to that of WT-G614, 26 while that of the Delta PV proved significantly higher ( Fig 7A) . Analyses in U2OS-ACE2-TMPRSS2 showed that the presence of TMPRSS2 led to an overall increase in PV 29 infectivity ( Fig 7C) . The relative differences in PV infectivity showed a pattern similar to that observed in 30 absence of TMPRSS2, except that the Delta PV showed an infectivity comparable rather than higher than 31 WT. Presence of the D614G mutation led to a full restoration of infectivity for the P681H PV, and to a 1 partial restoration for the P681R PV (Fig 7C, D) . In the Calu-3 cell line, which expresses ACE2 and TMPRSS2 endogenously [32], PV entry was lower than in 4 cell lines transduced with the ACE2 and TMPRSS2 receptor (Fig 7E) . The DFCS PV showed drastically 5 decreased infectivity in Calu-3, indicating that a functional FCS was required for efficient entry in this cell 6 line. The T761I PV still showed a decreased infectivity as compared to WT, while the P681H/R PV were as 7 infectious as WT in the Calu-3 setting. The Alpha PV also showed an infectivity comparable to WT-G614, 8 while infectivity of the Delta PV was significantly increased (Fig 7E) . The G614/D614 infectivity ratios were above 1 for all the PV tested ( Fig 7F) , indicating that the D614G 11 mutation increased infectivity in Calu-3 cells, though this increase appeared moderate compared to that 12 seen in other cell lines. Concerning the P681R/H mutants, the infectivity ratios were in the 1.5-2.5 range 13 in Calu-3, while they were in the 3-7 range HEK-ACE2 and U2OS-ACE2 +/-TMPRSS2, suggesting that the 14 compensatory effect of the D614G mutation depended on the cellular context. Viral entry in HEK-ACE2 cells was inhibited at 80% by E64D treatment for most PV tested, while the blocking 28 effect of Camostat was minimal (20%), suggesting that the endosomal entry route predominated in this 29 cell line (Fig 8A and S5A Fig) . The combination of E64D and Camostat resulted in an inhibition equivalent 30 to that seen with E64D alone, reinforcing the notion of a predominant endosomal entry. Entry inhibition 31 did not vary depending on the presence or absence of the D614G mutation, suggesting that spike stability 32 was not the main parameter determining the viral entry route. The Delta PV was characterized by a lower 1 susceptibility to entry blocking by the two protease inhibitors, possibly due to the high fusogenicity of the 2 Delta spike. Another exception was the T716I PV carrying the D614G mutation, which showed only 60% 3 inhibition by E64D treatment. However, this resistance was only relative, as this PV retained an overall low Analysis of entry inhibition in HEK-ACE2-TMPRSS2 showed an inverted pattern as compared to that seen 7 in HEK-ACE2, with about 80% inhibition by Camostat, and a negligible effect of E64D ( Fig 8B) . Thus, the 8 expression of TMPRSS2 was sufficient to switch entry pathways, with the surface route becoming 9 predominant. The Delta PV proved again less susceptible to entry inhibition. The other PV that showed 10 low (40%) entry inhibition by Camostat was DFCS, consistent with the limited capacity of an uncleaved 11 spike to promote surface entry. The DFCS PV were the only ones to show a degree of inhibition by E64D in 12 HEK-ACE2-TMPRSS2, suggesting that a limited access to the endosomal route remained available in the 13 presence of TMPRSS2. The presence of the D614G mutation had little or no effect on susceptibility to 14 protease inhibitors, suggesting that the main determinants of entry pathway usage lied with the host cell 15 rather than with the viral particle. E64D was in the 20-40% range, except for DFCS PV, which remained cathepsin-dependent for viral entry. 29 We noted that PV carrying G614 tended to be more susceptible to E64D inhibition than their D614 30 counterpart, suggesting that PV with stabilized spikes may still partially use the endosomal entry pathway 31 in the U2OS cellular context. Camostat did not inhibit viral entry in U2OS-ACE2 and, intriguingly, showed 32 also a limited effect (about 20% inhibition) in U2OS-ACE2-TMPRSS2 ( Fig 8E) . In contrast, the inhibitory 1 effect of E64D was maintained and even at time increased (20-60% range) in the presence of TMPRSS2. 2 When considering absolute infectivity values, addition of TMPRSS2 did increase viral entry in U2OS-ACE2 3 cells (S5E Fig). However, the expression of TMPRSS2 was not sufficient to entirely redirect viral entry to a 4 Camostat-dependent pathway, in contrast to findings obtained in HEK-ACE2-TMPRSS2 cells. The partial 5 entry inhibition observed with combined Camostat plus E64D treatment raised the possibility of an 6 additional entry route that would not depend on TMPRSS2 nor cathepsins. This study demonstrates that spikes carrying the S1/S2 cleavage site mutations characteristic of SARS-CoV-11 2 variants require the additional D614G mutation to maintain an efficient viral entry. The acquisition of 12 the D614G mutation was already viewed as a key event that enabled the worldwide dissemination of the 13 original SARS-CoV-2 strain [3, 4]. We report here that D614G is even more important for the fitness of 14 virions carrying the P681R/H mutations, in particular when the endosomal entry pathway predominates. 15 Indeed, the benefit conferred by D614G on infectivity was 1.5 to 3 times higher for pseudoviruses carrying 16 the P681R/H mutations than for those with the original P681 residue in HEK-ACE2 cells. Based on these 17 findings, we propose that acquisition of D614G played an essential role in the emergence of the highly 18 transmissible and pathogenic Alpha and Delta variants. 19 We had previously shown that P681H was the key mutation involved in conferring a higher fusogenicity to 20 the Alpha spike [36] . We report in the present study that the P681R mutation found in the Delta spike 21 confers an even higher fusogenic capacity, consistent with the recent literature [38, 40, 43] . In a D614 22 context, these highly fusogenic spikes were characterized by equivalent or slightly lower expression than 23 the Wuhan spike at the surface of producer cells, and by decreased incorporation into pseudotyped 24 virions. This may be due to differences in spike trafficking, as premature intracellular fusion events 25 triggered by the P681H/R spikes could perturb protein maturation pathways. Introduction of the D614G 26 mutation slightly increased the surface expression of the P681H spike, but not that of the P681R spike, 27 and did not restore incorporation of these spikes into virions. Thus, the D614G change must have acted 28 primarily after the virion release stage. The P681H/R spikes incorporated into virions showed a clear 29 increase in the degree of cleavage at the S1/S2 site, as expected [17, 39, 40] . Introduction of the D614G 30 mutation into the P681H/R spikes did not significantly change their degree of cleavage, as measured by 31 the S2/S0 ratio. The key difference proved to be in the degree of S1 subunit retention on virions, with an 32 S1/S2 ratio increased by a factor 2 to 3 in the presence of the D614G mutation. Of note, increased S1 1 retention was also seen when D614G was inserted into the original Wuhan spike, as reported here and in 2 previous studies [17, 22] . However, due to the higher cleavage rate achieved by the P681H/R spikes, the 3 proportion of S1 subunits retained in presence of the D614G was higher, accounting for the preferential 4 effect of the D614G change on highly fusogenic spikes. The infectivity enhancement conferred by the D614G mutation proved higher in the absence of TMPRSS2 7 overexpression. This was observed in the HEK-ACE2 as well as the U2OS-ACE2 cellular contexts. In addition, 8 the infectivity enhancement remained moderate in Calu-3 cells, which endogenously express TMPRSS2 9 and enable viral entry via the surface rather than the endosomal route [32]. A likely explanation for these 10 findings is that S1 subunit stability is more critical when using the endosomal rather than the TMPRSS2-11 dependent surface entry pathway. SARS-CoV-2 entry via the endosomal route was shown to take longer 12 than via the surface route, and to require endosomal acidification [31, 32] . A more stable spike is likely to 13 better withstand a long entry process and/or an acidifying environment. Ultrastructural studies suggest 14 that the release of S1 subunits facilitates the transition of the metastable spike trimer to a post-fusion 15 conformation, and that these changes may at times happen prematurely, before attachment of S1 to its 16 receptor ACE2 [4] . The presence of post-fusion trimers lacking S1 has for instance been documented at 17 the surface of virions by cryo-electron microscopy [44] , and it is possible that this phenomenon is further 18 triggered within endosomes. The D614G mutation may limit these premature conformational changes, as 19 this mutation was shown to stabilize the non-covalent association of the S1 and S2 subunits within a spike 20 protomer [22] . The stabilizing effect of the D614G mutation may thus be particularly relevant in the case 21 of pre-cleaved spikes with a high propensity for fusion, and in cellular contexts that favor the endosomal 22 entry route. 23 24 A spike devoid of the polybasic S1/S2 cleavage site (DFCS) proved defective in the cell-cell fusion assay. In 25 contrast, pseudotypes carrying this spike were highly infectious in the HEK-ACE2 and U2OS-ACE2 cellular 26 contexts, consistent with previous reports [25, 28, 45]. These observations highlight a disconnect between 27 fusogenic capacity measured at the cell surface and infectivity, likely due to differences in the subcellular 28 locations involved. Indeed, the DFCS spike was highly sensitive to E64D inhibition but only minimally 29 sensitive to camostat, and thus mediated entry almost exclusively by the endosomal route. This was 30 further confirmed by the low infectivity of DFCS pseudotypes in Calu-3 cells where the surface route 31 predominates, as previously reported [27] . The DFCS spike is deleted of the PRRA sequence, but still retains 32 an arginine at 685, and may thus be cleaved at this site (or at neighboring sites) by cathepsins, accounting 1 for its capacity to mediate entry through endosomes. Of note, presence of the D614G mutation did not 2 restore the fusogenic capacity of the DFCS spike, and induced only limited changes in its infectivity pattern. 3 Indeed, D614G tended to decrease, rather than increase, the infectivity of DFCS pseudotypes in HEK-ACE2 4 cells, slightly increased infectivity in U2OS-ACE2 cells, and had no effect on infectivity in Calu-3 cells. These 5 observations further support the notion that D614G acts through stabilization of S1/S2 association, as 6 D614G loses its effects in situations where S1 and S2 are covalently associated. The T716I mutation found in the Alpha spike had an overall deleterious effect on pseudotyped virus 23 infectivity, which was associated with decreased spike incorporation into virions. In addition, the T716I 24 mutation induced slightly less spike cleavage, but markedly lower retention of cleaved S1 subunits. Taken 25 together, the T716I change resulted in a low amount of functional spike carrying the S1 subunit on virions, 26 accounting for a low infectivity. These observations are compatible with structural studies showing that 27 the T716I mutation has a locally destabilizing effect, by abrogating an intra-spike protomer hydrogen bond 28 [47]. Combination of D614G with the T716I mutation did have a stabilizing effect, as S1 retention 29 improved. However, the infectivity of the D614G/T716I pseudotypes remained lower than that of other 30 mutants in all the cell lines tested. The presence of T716I change may help explain why Alpha pseudotypes 31 retain a low infectivity in HEK-ACE2 cells. On the other hand, Alpha pseudotypes are as infectious as WT 32 G614 pseudotypes in U2OS-ACE2 and Calu-3 cells, implying that the deleterious effect of T716I is 1 compensated by other mutations present in the Alpha spike. Reasons for the conservation of a 2 destabilizing mutation such as T716I remain to be fully elucidated, but may be related to the capacity of 3 the Alpha spike trimer to more frequently switch to an RBD up conformation competent for ACE2 binding 4 [47] . Overall, structural studies point to the interplay of several stabilizing and destabilizing mutations that 5 control the degree of exposure of the RBD. 6 7 Compensatory mutations that increase entry of the Alpha spike act through several mechanisms. A two 8 residues deletion found in the N-terminal domain of the Alpha spike, DH69V70, was reported to increase 9 total spike incorporation into virions [48] . In contrast, the D614G changes acts primarily through the 10 stabilization of the S1/S2 non-covalent association, as discussed above. The N501Y change found in the 11 RBD increases affinity of the spike for ACE2 by a factor up to 5, which promotes viral entry [23, 47].The 12 P681H mutation increased spike fusogenicity, which should have an impact on viral entry. However, P681H 13 by itself did not increase infectivity in our assays, consistent with a previous report [34] . Possible reasons 14 include the instability of the cleaved S1 subunit, which may not be fully compensated by the D614G 15 change, and a trend for lower incorporation of the P681H spike into viral particles. While the P681H change Omicron trimer, which may slow down the transition of the RBD to the up position, and thus make ACE2 32 binding a rate limiting step in viral entry [52] . Residues close to the FCS also appear more structured, which 1 may limit access of the furin enzyme, and account for the low cleavage rate. Thus, low fusogenicity of 2 Omicron appears to result from combinatorial changes that restrict several steps of the entry process, but 3 accommodate a wide array of immune escape mutations. on the D614G mutation for S1 subunit stabilization. We report that the dependency on the D614G 10 mutation was more marked for highly fusogenic spikes, implying a key role of the D614G mutation in the 11 emergence of highly pathogenic SARS-CoV-2 variants. supplemented with 1 µg/mL and 4 µg/mL of puromycin, respectively. All the cell lines were cultured at 10 37°C under a 5% CO2 atmosphere, and were routinely screened for mycoplasma. 13 Transfection was performed with Lipofectamine 2000 (ThermoFisher, #11668019), using 125 ng of Infection with spike-pseudotyped lentivectors 6 The day before infection with spike-pseudotyped GFP-lentivectors, 100,000 HEK-ACE2-TMPRSS2 cells 7 were plated in 96-well plates, and TMPRSS2 was induced when needed by the addition of doxycycline. Western blotting 30 To prepare protein extracts, 2 millions of cells were lysed in buffer containing 150 mM NaCl, 50 mM Tris 31 HCl (pH8), 1% Triton, 5mM EDTA, with 1x protease inhibitor cocktail (Roche, #11873580001) for 30 min on 32 ice. For lentiviral particle extracts, an equivalent of 300 ng of Gag p24 was lysed in ELISA lysis buffer 1 containing 1% Triton (Alliance HIV-1 p24 Antigen ELISA kit, Perkin Elmer) and protease inhibitors for 30 2 min on ice. Samples were heated and reduced in 1x final DTT buffer (Thermofisher, #NP0004) at 90°C for 3 10 min before being run on a 4-12% acrylamide denaturing gel (ThermoFisher, #NP0323 NuPAGE). Proteins 4 were then transferred onto a nitrocellulose membrane (ThermoFisher, #IB23001). The membrane was 5 blocked with 5% dried milk in PBS Tween 0.1 %, before incubation with three primary antibodies (S1, S2, 6 and p24 Gag or actin) for 1h at room temperature (RT), followed by 3 washes in PBS Tween 0.1 %, and To evaluate ACE2 and TMPRSS2 expression in the target cell lines used, cells were surface-labelled with 7 the goat anti-ACE2 antibody (R&D #AF933) at 5 mg/mL for 30 min at 4°C. After washing, cells were 8 incubated with the secondary antibody donkey anti-goat-AF647 (ThermoFisher #A21447) at a 1:500 9 dilution. Cells were then permeabilized with the Fix/Perm kit (BD Biosciences #554714) according to 10 manufacturer recommendations. Cells were intracellularly stained with a rabbit anti-TMPRSS2 antibody 11 (Atlas antibodies, HPA035787) at 0.3 mg/mL. After washing, the secondary staining was done with a 12 donkey anti-rabbit-AF555 antibody (Fisher #16229260) at a 1:500 dilution. Cells were then fixed in 2% PFA 13 and analyzed by flow cytometry as described above. (C) Ratio of total spike incorporated measured in the G614 backbone to that in the D614 backbone. 32 (D) Quantitation of total cleaved spike, measured by the S2/S0 ratio, and normalized to WT. 1 (E) Ratio of total cleaved spike measured in the G614 backbone to that in the D614 backbone. 2 (F) Quantitation of S1 subunit retention in PV particles, measured by the S1/S2 ratio, and normalized to 3 WT. ND: not detectable. 4 (G) Ratio of S1 retention measured in the G614 backbone to that in the D614 backbone. 13 The infectivity of GFP-lentivector pseudotyped with the different spikes was analyzed in HEK-ACE2 cells 14 induced or not for TMPRSS2 expression. 12 The different forms of spike present into HEK 293Tn cells transfected for GFP-pseudotyped viruses (PV) 13 production were analyzed by Western blotting on cell lyzates. 14 (A) Representative Western blot showing the S1 (green) and S2 (red) spike subunits, and the actin protein Isotype-AF647 ACE2-AF647 TMPRSS2-AF555 The biological and clinical 3 significance of emerging SARS-CoV-2 variants Discovery of an RNA 6 virus 3'->5' exoribonuclease that is critically involved in coronavirus RNA synthesis Evidence that D614G Increases Infectivity of the COVID-19 Virus. Cell. 2020 Mechanisms of SARS-CoV-2 entry into cells Tracking SARS-CoV-2 variants 2022 Estimated transmissibility 16 and impact of SARS-CoV-2 lineage B.1.1.7 in England Evolution of enhanced 19 innate immune evasion by SARS-CoV-2 Enhanced fitness of SARS-CoV-2 variant 22 Attenuated fusogenicity and 11 pathogenicity of SARS-CoV-2 Omicron variant Considerable escape 14 of SARS-CoV-2 Omicron to antibody neutralization Early assessment of the clinical 17 severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study SARS-CoV-2 spike-protein D614G 20 mutation increases virion spike density and infectivity